Previous studies have suggested an inverse correlation between Gal-9 expression and cancer progression in several solid tumors, including breast, gallbladder, and colon cancers, as well as cervical squamous cell carcinoma and hepatocellular carcinoma (3, 5–8). This evidence concerns the gene LGALS9 and colonic neoplasm.